Antagonism of WT1 activity by protein self-association
- PMID: 7479946
- PMCID: PMC40580
- DOI: 10.1073/pnas.92.24.11105
Antagonism of WT1 activity by protein self-association
Abstract
Germline loss-of-function mutations at the Wilms tumor (WT) suppressor locus WT1 are associated with a predisposition to WTs and mild genital system anomalies. In contrast, germ-line missense mutations within the WT1 gene encoding the DNA-binding domain often yield a more severe phenotype consisting of WT, sexual ambiguity, and renal nephropathy. In this report, we demonstrate that the products of mutant alleles that impair DNA recognition can antagonize WT1-mediated transcriptional repression. We demonstrate that WT1 can self-associate in vitro and in vivo and that the responsible domain maps to the amino-terminal region of the protein. Oligomers of full-length protein form less efficiently or produce less stable complexes than oligomers between truncated polypeptides and full-length protein. Our data suggest a molecular mechanism to explain how WT1 mutations may act in deregulating cellular proliferation and differentiation.
Similar articles
-
Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.Oncogene. 1995 Mar 16;10(6):1125-9. Oncogene. 1995. PMID: 7700638
-
Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.Endocrinology. 1999 Oct;140(10):4713-24. doi: 10.1210/endo.140.10.7065. Endocrinology. 1999. PMID: 10499530
-
Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.J Biol Chem. 2002 Nov 22;277(47):44826-37. doi: 10.1074/jbc.M205667200. Epub 2002 Sep 17. J Biol Chem. 2002. PMID: 12239212
-
Wilms tumor and the WT1 gene.Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131. Exp Cell Res. 2001. PMID: 11237525 Review.
-
A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.Pediatr Nephrol. 2005 Jan;20(1):81-5. doi: 10.1007/s00467-004-1649-z. Epub 2004 Oct 21. Pediatr Nephrol. 2005. PMID: 15503171 Review.
Cited by
-
Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.Nucleic Acids Res. 2018 May 4;46(8):3864-3877. doi: 10.1093/nar/gkx1274. Nucleic Acids Res. 2018. PMID: 29294058 Free PMC article.
-
Frasier and Denys-Drash syndromes: different disorders or part of a spectrum?Arch Dis Child. 1999 Oct;81(4):365-9. doi: 10.1136/adc.81.4.365. Arch Dis Child. 1999. PMID: 10490448 Free PMC article. Review. No abstract available.
-
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.Mol Cell Biol. 1996 Dec;16(12):6945-56. doi: 10.1128/MCB.16.12.6945. Mol Cell Biol. 1996. PMID: 8943350 Free PMC article.
-
Immunotherapy Applications for Thymine Dimers and WT1 Antigen in Renal Cancers: A Comparative Statistical Analysis.J Pers Med. 2024 May 23;14(6):557. doi: 10.3390/jpm14060557. J Pers Med. 2024. PMID: 38929778 Free PMC article.
-
Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.PLoS One. 2015 Jun 19;10(6):e0130578. doi: 10.1371/journal.pone.0130578. eCollection 2015. PLoS One. 2015. PMID: 26090994 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources